FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

39970211000001101: Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Sep 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2001671000001112 Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2001681000001114 Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose Has VMP Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Olopatadine true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose Has specific active ingredient Mometasone furoate true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose Has specific active ingredient Olopatadine hydrochloride true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) 240 dose Is a True Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start